Yes — under the planned 2026 iPLEDGE changes, your prescriber may allow you to take required pregnancy tests at home during and after isotretinoin treatment. iPLEDGE is the FDA safety program for isotretinoin, a strong acne drug that can cause severe birth defects.
Your first test before starting treatment must still occur in a medical setting, according to the National Community Pharmacists Association update the association's February update. The changes are now scheduled to start Nov. 15, 2026, to allow time to test system updates, as reported by Lachman Consultants Lachman Consultants' June report.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What will home testing cover?
- When will the new option start?
- What still has to happen every month?
- How can you avoid a wrong or rejected result?
What will home testing cover?
Home testing is planned as an option during treatment and in the follow-up period after you stop isotretinoin. Your prescriber decides whether you may use it. Drugs.com reporting on the FDA action says the goal was to lower burden on patients, prescribers, and pharmacies while keeping safe use.
The starting test is different. You must still have pre-treatment testing in a medical setting. If you are an adult beginning isotretinoin for stubborn acne, plan that first visit as an in-person test.
When will the new option start?
FDA approved the changes on Feb. 9, 2026. They were first set to take effect about 180 days later, around Aug. 8-9, 2026. Enforcement flexibility in place since Oct.
2023 would continue until then, as described by American Pharmacy News reporting on FDA. Lachman Consultants reporting on the FDA announcement says FDA later moved the date to Nov. 15, 2026. The extra time lets staff test iPLEDGE system updates and avoid gaps in access. Ask your clinic closer to that date whether its home-testing process is ready.
What still has to happen every month?
Monthly pregnancy tests are still required if you can become pregnant. You must also pick up isotretinoin within 7 days of the test. Isotretinoin is highly teratogenic, and iPLEDGE aims to prevent fetal exposure, according to the FDA iPLEDGE Prescriber Guide the prescriber guide.
Teratogenic means it can seriously harm an unborn child. Plan testing around refill dates and message your care team early if travel or illness may delay you. Put your test date, prescription window, and pickup plan into one calendar reminder.
How can you avoid a wrong or rejected result?
If you miss the 7-day window, FDA removed the old 19-day lockout, so a repeat test can be done right away with no added wait. Prescribers who allow home testing must set up steps to reduce misreading and falsified results. The Journal of Dermatology for NPs/PAs reports both updates in its February coverage.
Ask your prescriber for exact instructions before you rely on a home test. Clinics may differ on timing, reporting, and proof, so use their written steps each month. If a result looks unclear, do not start a new pack. Call your prescriber the same day for guidance on retesting.
- which test to buy and when to take it
- how to time the test with your prescription window
- how to send the result, such as portal photo or in-person check
- what to do if the result is unclear or positive
You Might Also Like
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: Access and Prescription-Window Questions for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Access and Prescription-Window Questions for Adult Acne Patients
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: A Verification Checklist for Adult Acne Patients